Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Short term Debt (2018 - 2022)

NovaBridge Biosciences (NBP) has disclosed Short term Debt for 3 consecutive years, with $2.7 million as the latest value for Q4 2022.

  • Quarterly Short term Debt changed N/A to $2.7 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $2.7 million through Dec 2022, changed N/A year-over-year, with the annual reading at $2.7 million for FY2022, N/A changed from the prior year.
  • Short term Debt for Q4 2022 was $2.7 million at NovaBridge Biosciences, down from $7.1 million in the prior quarter.
  • The five-year high for Short term Debt was $11.6 million in Q4 2018, with the low at $2.7 million in Q4 2022.
  • Average Short term Debt over 3 years is $7.1 million, with a median of $7.1 million recorded in 2019.
  • Peak annual rise in Short term Debt hit 38.69% in 2019, while the deepest fall reached 38.69% in 2019.
  • Over 3 years, Short term Debt stood at $11.6 million in 2018, then tumbled by 38.69% to $7.1 million in 2019, then crashed by 62.43% to $2.7 million in 2022.
  • According to Business Quant data, Short term Debt over the past three periods came in at $2.7 million, $7.1 million, and $11.6 million for Q4 2022, Q4 2019, and Q4 2018 respectively.